|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kuipers EJ, Grady WM, Lieberman D,
Seufferlein T, Sung JJ, Boelens PG, van de Velde CJ and Watanabe T:
Colorectal cancer. Nat Rev Dis Primers. 1:150652015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xie YH, Chen YX and Fang JY: Comprehensive
review of targeted therapy for colorectal cancer. Signal Transduct
Target Ther. 5:222020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brown KGM, Solomon MJ, Mahon K and
O'Shannassy S: Management of colorectal cancer. BMJ. 366:l45612019.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Vodenkova S, Buchler T, Cervena K,
Veskrnova V, Vodicka P and Vymetalkova V: 5-fluorouracil and other
fluoropyrimidines in colorectal cancer: Past, present and future.
Pharmacol Ther. 206:1074472020. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Xie P, Mo JL, Liu JH, Li X, Tan LM, Zhang
W, Zhou HH and Liu ZQ: Pharmacogenomics of 5-fluorouracil in
colorectal cancer: Review and update. Cell Oncol (Dordr).
43:989–1001. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yu C, Hao X, Zhang S, Hu W, Li J, Sun J
and Zheng M: Characterization of the prognostic values of the NDRG
family in gastric cancer. Therap Adv Gastroenterol.
12:17562848198585072019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shi HH, Liu HE and Luo XJ:
Hypermethylation-mediated silencing of NDRG4 promotes pancreatic
ductal adenocarcinoma by regulating mitochondrial function. BMB
Rep. 53:658–663. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cao L, Hu T, Lu H and Peng D: N-MYC
downstream regulated gene 4 (NDRG4), a frequent downregulated gene
through DNA hypermethylation, plays a tumor suppressive role in
esophageal adenocarcinoma. Cancers (Basel). 12:25732020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen X, Yang Y, Liu J, Li B, Xu Y, Li C,
Xu Q, Liu G, Chen Y, Ying J and Duan S: NDRG4 hypermethylation is a
potential biomarker for diagnosis and prognosis of gastric cancer
in Chinese population. Oncotarget. 8:8105–8119. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kadiyska T and Nossikoff A: Stool DNA
methylation assays in colorectal cancer screening. World J
Gastroenterol. 21:10057–10061. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Puthalakath H, O'Reilly LA, Gunn P, Lee L,
Kelly PN, Huntington ND, Hughes PD, Michalak EM, McKimm-Breschkin
J, Motoyama N, et al: ER stress triggers apoptosis by activating
BH3-only protein Bim. Cell. 129:1337–1349. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li L, Chen Q, Yu Y, Chen H, Lu M, Huang Y,
Li P and Chang H: RKI-1447 suppresses colorectal carcinoma cell
growth via disrupting cellular bioenergetics and mitochondrial
dynamics. J Cell Physiol. 235:254–266. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tan W, Liao Y, Qiu Y, Liu H, Tan D, Wu T,
Tang M, Zhang S and Wang H: MiRNA 146a promotes chemotherapy
resistance in lung cancer cells by targeting DNA damage inducible
transcript 3 (CHOP). Cancer Lett. 428:55–68. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cao Z, Liao Q, Su M, Huang K, Jin J and
Cao D: AKT and ERK dual inhibitors: The way forward? Cancer Lett.
459:30–40. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dekker E, Tanis PJ, Vleugels JLA, Kasi PM
and Wallace MB: Colorectal cancer. Lancet. 394:1467–1480. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stintzing S: Management of colorectal
cancer. F1000Prime Rep. 6:1082014. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sargent D, Sobrero A, Grothey A, O'Connell
MJ, Buyse M, Andre T, Zheng Y, Green E, Labianca R, O'Callaghan C,
et al: Evidence for cure by adjuvant therapy in colon cancer:
Observations based on individual patient data from 20,898 patients
on 18 randomized trials. J Clin Oncol. 27:872–877. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Blondy S, David V, Verdier M, Mathonnet M,
Perraud A and Christou N: 5-Fluorouracil resistance mechanisms in
colorectal cancer: From classical pathways to promising processes.
Cancer Sci. 111:3142–3154. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Uppada SB, Gowrikumar S, Ahmad R, Kumar B,
Szeglin B, Chen X, Smith JJ, Batra SK, Singh AB and Dhawan P: MASTL
induces colon cancer progression and chemoresistance by promoting
Wnt/β-catenin signaling. Mol Cancer. 17:1112018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sun Y, Jiang Y, Huang J, Chen H, Liao Y
and Yang Z: CISD2 enhances the chemosensitivity of gastric cancer
through the enhancement of 5-FU-induced apoptosis and the
inhibition of autophagy by AKT/mTOR pathway. Cancer Med.
6:2331–2346. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liang Y, Hou L, Li L, Li L, Zhu L, Wang Y,
Huang X, Hou Y, Zhu D, Zou H, et al: Dichloroacetate restores
colorectal cancer chemosensitivity through the
p53/miR-149-3p/PDK2-mediated glucose metabolic pathway. Oncogene.
39:469–485. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Qu X, Zhai Y, Wei H, Zhang C, Xing G, Yu Y
and He F: Characterization and expression of three novel
differentiation-related genes belong to the human NDRG gene family.
Mol Cell Biochem. 229:35–44. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vaes N, Lentjes MHFM, Gijbels MJ,
Rademakers G, Daenen KL, Boesmans W, Wouters KAD, Geuzens A, Qu X,
Steinbusch HPJ, et al: NDRG4, an early detection marker for
colorectal cancer, is specifically expressed in enteric neurons.
Neurogastroenterol Motil. 29:2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kisiel JB, Klepp P, Allawi HT, Taylor WR,
Giakoumopoulos M, Sander T, Yab TC, Moum BA, Lidgard GP, Brackmann
S, et al: Analysis of DNA methylation at specific loci in stool
samples detects colorectal cancer and high-grade dysplasia in
patients with inflammatory bowel disease. Clin Gastroenterol
Hepatol. 17:914–921 e5. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chu D, Zhang Z, Zhou Y, Li Y, Zhu S, Zhang
J, Zhao Q, Ji G, Wang W and Zheng J: NDRG4, a novel candidate tumor
suppressor, is a predictor of overall survival of colorectal cancer
patients. Oncotarget. 6:7584–7596. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zheng J, Li Y, Zhu S, Li J, Zhao Q, Ji G,
Wang W and Chu D: NDRG4 stratifies the prognostic value of body
mass index in colorectal cancer. Oncotarget. 7:1311–1322. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Milczarek M, Rossowska J, Klopotowska D,
Stachowicz M, Kutner A and Wietrzyk J: Tacalcitol increases the
sensitivity of colorectal cancer cells to 5-fluorouracil by
downregulating the thymidylate synthase. J Steroid Biochem Mol
Biol. 190:139–151. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lu P, Xu M, Xiong Z, Zhou F and Wang L:
Fusobacterium nucleatum prevents apoptosis in colorectal cancer
cells via the ANO1 pathway. Cancer Manag Res. 11:9057–9066. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang CM, Kang MK, Jung WJ, Joo JS, Kim YJ,
Choi Y and Kim HP: p53 expression confers sensitivity to
5-fluorouracil via distinct chromatin accessibility dynamics in
human colorectal cancer. Oncol Lett. 21:2262021. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Palma S, Raffa CI, Garcia-Fabiani MB,
Ferretti VA, Zwenger A, Perez Verdera PV, Llontop A, Rojas Bilbao
E, Cuartero V, Abba MC and Lacunza E: RHBDD2 overexpression
promotes a chemoresistant and invasive phenotype to rectal cancer
tumors via modulating UPR and focal adhesion genes. Biochim Biophys
Acta Mol Basis Dis. 1866:1658102020. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yao RQ, Ren C, Xia ZF and Yao YM:
Organelle-specific autophagy in inflammatory diseases: A potential
therapeutic target underlying the quality control of multiple
organelles. Autophagy. 17:385–401. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang X, Zhou T, Li W, Zhang T, Che N and
Zu G: Clinicopathological and prognostic significance of C/EBP
homologous protein (CHOP) in advanced gastric cancer. Pathol Res
Pract. 214:1105–1109. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ji DB and Wu AW: Organoid in colorectal
cancer: Progress and challenges. Chin Med J (Engl). 133:1971–1977.
2020. View Article : Google Scholar : PubMed/NCBI
|
